PIQ.AX ASX
Proteomics International Laboratories Ltd.
1W: +4.3%
1M: -22.6%
3M: -22.6%
YTD: -73.6%
1Y: -60.0%
3Y: -86.7%
5Y: -88.9%
A$0.12 ($0.09)
+0.01 (+4.17%)
Weekly Expected Move ±12.2%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$6M
+11.1% ▲
Capital Expenditures
$2M
-6690.3% ▼
5Y CAGR: +57.9%
Free Cash Flow
-$8M
-18.8% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$8M
-271.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$5M | -$6M | -$6M | $0 | -$9M |
| Depreciation & Amort. | $417K | $530K | $728K | $0 | $810K |
| Stock-Based Comp. | $512K | $324K | $0 | $0 | $0 |
| Change in Working Capital | -$139K | $294K | -$669K | $0 | $1M |
| Other Non-Cash Items | $1M | -$46K | $725K | -$7M | $467K |
| Operating Cash Flow | -$4M | -$6M | -$6M | -$7M | -$6M |
| — Investing Activities — | |||||
| Capital Expenditures | -$129K | -$1M | -$403K | -$30K | -$2M |
| Acquisitions (Net) | $0 | $53K | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $53K | $15K | $0 | $0 |
| Investing Cash Flow | -$129K | -$1M | -$388K | -$30K | -$2M |
| — Financing Activities — | |||||
| Net Debt Issuance | $245K | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$314K | -$66K | -$35K | -$173K | -$338K |
| Financing Cash Flow | $176K | $11M | $7M | $11M | $345K |
| Net Change in Cash | -$3M | $4M | $613K | $4M | -$8M |
| Cash End of Period | $2M | $6M | $7M | $11M | $3M |
| Free Cash Flow | -$4M | -$7M | -$6M | -$7M | -$8M |